Chemical target validation studies of aminopeptidase in malaria parasites using α-aminoalkylphosphonate and phosphonopeptide inhibitors

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 9, 2008, Pages 3221-3228

  Cunningham, Eithne ^a   Drag, Marcin ^b,c   Kafarski, Pawel ^b   Bell, Angus ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^c BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; BESTATIN; PHOSPHONIC ACID DERIVATIVE;

ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN TARGETING; VALIDATION STUDY;

AMINOPEPTIDASES; ANIMALS; ANTIMALARIALS; GLUTAMYL AMINOPEPTIDASE; HUMANS; LEUCYL AMINOPEPTIDASE; PARASITIC SENSITIVITY TESTS; PEPTIDES; PHOSPHONIC ACIDS; PLASMODIUM FALCIPARUM; PROTEASE INHIBITORS;

EID: 50949112789     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01327-07     Document Type: Article

References (40)

1. Allary, M., J. Schrével, and I. Florent. 2002. Properties, stage-dependent expression and localization of Plasmodium falciparum M1 family zinc-aminopeptidase. Parasitology 125:1-10.
2. Bonilla, J. A., T. D. Bonilla, C. A. Yowell, H. Fujioka, and J. B. Dame. 2007. Critical roles for the digestive vacuole plasmepsins of Plasmodium falciparum in vacuolar function. Mol. Microbiol. 65:64-75.
3. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
4. Charet, P., E. Aissi, P. Maurois, S. Bouquelet, and J. Biguet. 1980. Aminopeptidase in rodent Plasmodium. Comp. Biochem. Physiol. B 65:519-524.
5. Chen, X., C. R. Chong, L. Shi, T. Yoshimoto, D. J. Sullivan, Jr., and J. O. Liu. 2006. Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activity. Proc. Natl. Acad. Sci. USA 103:14548-14553.
6. Dalal, S., and M. Klemba. 2007. Roles for two aminopeptidases in vacuolar hemoglobin catabolism in Plasmodium falciparum. J. Biol. Chem. 282:35978-35987.
7. Drag, M., J. Grembecka, M. Pawelczak, and P. Kafarski. 2005. α-Aminoalkylphosphonates as a tool in experimental optimisation of P1 side chain shape of potential inhibitors in S1 pocket of leucine- and neutral aminopeptidases. Eur. J. Med. Chem. 40:764-771.
8. Drag, M., R. Latajka, E. Gumienna-Kontecka, H. Kozlowski, and P. Kafarski. 2003. Stereoselective synthesis, solution structure and metal complexes of (1S,2S)-2-amino-1-hydroxyalkylphosphonic acids. Tetrahedron Asymmetry 14:1837-1845.
9. Edwards, G., and G. A. Biagini. 2006. Resisting resistance: dealing with the irrepressible problem of malaria. Br. J. Clin. Pharmacol. 61:690-693.
10. Ersmark, K., B. Samuelsson, and A. Hallberg. 2006. Plasmepsins as potential targets for new antimalarial therapy. Med. Res. Rev. 26:626-666.
11. Fennell, B. J., J. A. Naughton, E. Dempsey, and A. Bell. 2006. Cellular and molecular actions of dinitroaniline and phosphorothioamidate herbicides on Plasmodium falciparum: tubulin as a specific antimalarial target. Mol. Biochem. Parasitol. 145:226-238.
12. Flipo, M., T. Beghyn, V. Leroux, I. Florent, B. P. Deprez, and R. F. Deprez-Poulain. 2007. Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents. J. Med. Chem. 50:1322-1334.
13. Flipo, M., I. Florent, P. Grellier, C. Sergheraert, and R. Deprez-Poulain. 2003. Design, synthesis and antimalarial activity of novel, quinoline-based, zinc metallo-aminopeptidase inhibitors. Bioorg. Med. Chem. Lett. 13:2659-2662.
14. Florent, I., Z. Derhy, M. Allary, M. Monsigny, R. Mayer, and J. Schrével. 1998. A Plasmodium falciparum aminopeptidase gene belonging to the M1 family of zinc-metallopeptidases is expressed in erythrocytic stages. Mol. Biochem. Parasitol. 97:149-160.
15. Gardiner, D. L., K. R. Trenholme, T. S. Skinner-Adams, C. M. Stack, and J. P. Dalton. 2006. Overexpression of leucyl aminopeptidase in Plasmodium falciparum parasites. Target for the antimalarial activity of bestatin. J. Biol. Chem. 281:1741-1745.
16. Gavigan, C. S., J. P. Dalton, and A. Bell. 2001. The role of aminopeptidases in haemoglobin degradation in Plasmodium falciparum-infected erythrocytes. Mol. Biochem. Parasitol. 117:37-48.
17. Gavigan, C. S., S. G. Machado, J. P. Dalton, and A. Bell. 2001. Analysis of antimalarial synergy between bestatin and endoprotease inhibitors using statistical response-surface modelling. Antimicrob. Agents Chemother. 45:3175-3181.
18. Giannousis, P. P., and P. A. Bartlett. 1987. Phosphorus amino acid analogues as inhibitors of leucine aminopeptidase. J. Med. Chem. 30:1603-1609.
19. Goldberg, D. E. 2005. Hemoglobin degradation. Curr. Top. Microbiol. Immunol. 295:275-291.
20. Grembecka, J., and P. Kafarski. 2001. Leucine aminopeptidase as a target for inhibitor design. Mini Rev. Med. Chem. 1:133-144.
21. Gyang, F. N., B. Poole, and W. Trager. 1982. Peptidases from Plasmodium falciparum cultured in vitro. Mol. Biochem. Parasitol. 5:263-273.
22. Hamilton, R., B. Walker, and B. J. Walker. 1995. A highly convenient route to optically pure α-aminophosphonic acids. Tetrahedron Lett. 36:4451-4454.
23. Kafarski, P., and B. Lejczak. 1989. Mixed carboxylic-carbonic anhydride method in phosphonopeptide synthesis. Tetrahedron 45:7387-7396.
24. Kowalik, J., L. Kupczyk-Subotkowska, and P. Mastalerz. 1981. Preparation of dialkyl 1-aminoalkanephosphonates by reduction of dialkyl 1-hydroxyiminoalkanephosphonates with zinc in formic acid. Synthesis 1981:57-58.
25. Liu, J., E. S. Istvan, I. Y. Gluzman, J. Gross, and D. E. Goldberg. 2006. Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems. Proc. Natl. Acad. Sci. USA 103:8840-8845.
26. Makler, M. T., J. M. Ries, J. A. Williams, J. E. Bancroft, R. C. Piper, B. L. Gibbins, and D. J. Hinrichs. 1993. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am. J. Trop. Med. Hyg. 48:739-741.
27. Nankya-Kitaka, M. F., G. P. Curley, C. S. Gavigan, A. Bell, and J. P. Dalton. 1998. Plasmodium chabaudi chabaudi and P. falciparum: inhibition of aminopeptidase and parasite growth by bestatin and nitrobestatin. Parasitol. Res. 84:552-558.
28. Oleksyszyn, J., R. Tyka, and P. Mastalerz. 1978. Direct synthesis of 1-aminoalkanephosphonic and 1-aminoalkanephosphinic acids from phosphorus trichloride or dichlorophosphines. Synthesis 1978:479-480.
29. Rawlings, N. D., and A. J. Barrett. 1993. Evolutionary families of peptidases. Biochem. J. 290:205-218.
30. Rawlings, N. D., F. R. Morton, and A. J. Barrett. 2006. MEROPS: the peptidase database. Nucleic Acids Res. 34:D270-D272.
31. Rosenthal, P. J. 2004. Cysteine proteases of malaria parasites. Int. J. Parasitol. 34:1489-1499.
32. Scornik, O. A., and V. Botbol. 2001. Bestatin as an experimental tool in mammals. Curr. Drug Metab. 2:67-85.
33. Sijwali, P. S., J. Koo, N. Singh, and P. J. Rosenthal. 2006. Gene disruptions demonstrate independent roles for the four falcipain cysteine proteases of Plasmodium falciparum. Mol. Biochem. Parasitol. 150:96-106.
34. Skinner-Adams, T. S., J. Lowther, F. Teuscher, C. M. Stack, J. Grembecka, A. Mucha, P. Kafarski, K. R. Trenholme, J. P. Dalton, and D. L. Gardiner. 2007. Identification of phosphinatc dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds. J. Med. Chem. 50:6024-6031.
35. Stack, C. M., J. Lowther, E. Cunningham, S. Donnelly, D. L. Gardiner, K. R. Trenholme, T. S. Skinner-Adams, F. Teuscher, J. Grembecka, A. Mucha, P. Kafarski, L. Lua, A. Bell, and J. P. Dalton. 2007. Characterization of the Plasmodium falciparum M17 leucyl aminopeptidase. A protease involved in amino acid regulation with potential for antimalarial drug development. J. Biol. Chem. 282:2069-2080.
36. Szewczyk, J., B. Lejczak, and P. Kafarski. 1982. Transesterification of diphenyl phosphonates using the potassium fluoride/crown ether/alcohol system. Part 2. The use of diphenyl 1-aminoalkanephosphonates in phosphonopeptide synthesis. Synthesis 1982:409-412.
37. Vander Jagt, D. L., B. R. Baack, and L. A. Hunsaker. 1984. Purification and characterization of an aminopeptidase from Plasmodium falciparum. Mol. Biochem. Parasitol. 10:45-54.
38. Wu, Y., X. Wang, X. Liu, and Y. Wang. 2003. Data-mining approaches reveal hidden families of proteases in the genome of malaria parasite. Genome Res. 13:601-616.
39. Zhang, P., D. E. Nicholson, J. M. Bujnicki, X. Su, J. J. Brendle, M. Ferdig, D. E. Kyle, W. K. Milhous, and P. K. Chiang. 2002. Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis. J. Biomed. Sci. 9:34-40.
40. Zuckerman, A., D. Spira, and J. Hamburger. 1967. A procedure for the harvesting of mammalian Plasmodia. Bull. W. H. O. 37:431-436.